NEXGEL, Inc.
NEXGEL, Inc. NXGLW Peers
See (NXGLW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NXGLW | $0.25 | +0.00% | 20M | -0.22 | -$1.39 | N/A |
| ISRG | $543.41 | +0.00% | 192.8B | 78.77 | $6.83 | N/A |
| BDX | $172.25 | +0.00% | 50.9B | 34.43 | $5.16 | +2.29% |
| BDXA | $59.24 | -2.24% | 48.7B | 21.44 | $2.76 | +2.29% |
| ALC | $88.28 | +0.00% | 44B | 39.56 | $2.25 | +0.37% |
| RMD | $258.00 | +0.00% | 37.6B | 28.76 | $8.91 | +0.83% |
| BAX | $30.28 | +0.00% | 16B | -60.04 | -$0.52 | +2.57% |
| WST | $218.80 | +0.00% | 16B | 34.91 | $6.37 | +0.37% |
| HOLX | $65.16 | +0.00% | 14.6B | 27.45 | $2.38 | N/A |
| COO | $71.16 | +0.00% | 14.5B | 35.17 | $2.07 | N/A |
Stock Comparison
NXGLW vs ISRG Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ISRG has a market cap of 192.8B. Regarding current trading prices, NXGLW is priced at $0.25, while ISRG trades at $543.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ISRG's P/E ratio is 78.77. In terms of profitability, NXGLW's ROE is -0.63%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, NXGLW is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BDX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, BDX has a market cap of 50.9B. Regarding current trading prices, NXGLW is priced at $0.25, while BDX trades at $172.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas BDX's P/E ratio is 34.43. In terms of profitability, NXGLW's ROE is -0.63%, compared to BDX's ROE of +0.06%. Regarding short-term risk, NXGLW is more volatile compared to BDX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BDXA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, BDXA has a market cap of 48.7B. Regarding current trading prices, NXGLW is priced at $0.25, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas BDXA's P/E ratio is 21.44. In terms of profitability, NXGLW's ROE is -0.63%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, NXGLW is more volatile compared to BDXA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ALC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ALC has a market cap of 44B. Regarding current trading prices, NXGLW is priced at $0.25, while ALC trades at $88.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ALC's P/E ratio is 39.56. In terms of profitability, NXGLW's ROE is -0.63%, compared to ALC's ROE of +0.07%. Regarding short-term risk, NXGLW is more volatile compared to ALC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs RMD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, RMD has a market cap of 37.6B. Regarding current trading prices, NXGLW is priced at $0.25, while RMD trades at $258.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas RMD's P/E ratio is 28.76. In terms of profitability, NXGLW's ROE is -0.63%, compared to RMD's ROE of +0.25%. Regarding short-term risk, NXGLW is more volatile compared to RMD. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BAX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, BAX has a market cap of 16B. Regarding current trading prices, NXGLW is priced at $0.25, while BAX trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas BAX's P/E ratio is -60.04. In terms of profitability, NXGLW's ROE is -0.63%, compared to BAX's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to BAX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs WST Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, WST has a market cap of 16B. Regarding current trading prices, NXGLW is priced at $0.25, while WST trades at $218.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas WST's P/E ratio is 34.91. In terms of profitability, NXGLW's ROE is -0.63%, compared to WST's ROE of +0.17%. Regarding short-term risk, NXGLW is more volatile compared to WST. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HOLX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, HOLX has a market cap of 14.6B. Regarding current trading prices, NXGLW is priced at $0.25, while HOLX trades at $65.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas HOLX's P/E ratio is 27.45. In terms of profitability, NXGLW's ROE is -0.63%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, NXGLW is more volatile compared to HOLX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs COO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, COO has a market cap of 14.5B. Regarding current trading prices, NXGLW is priced at $0.25, while COO trades at $71.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas COO's P/E ratio is 35.17. In terms of profitability, NXGLW's ROE is -0.63%, compared to COO's ROE of +0.05%. Regarding short-term risk, NXGLW is more volatile compared to COO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BDXB Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, NXGLW is priced at $0.25, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas BDXB's P/E ratio is 7.60. In terms of profitability, NXGLW's ROE is -0.63%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, NXGLW is more volatile compared to BDXB. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ATR has a market cap of 10.5B. Regarding current trading prices, NXGLW is priced at $0.25, while ATR trades at $156.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ATR's P/E ratio is 29.09. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATR's ROE of +0.15%. Regarding short-term risk, NXGLW is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MASI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, MASI has a market cap of 9.2B. Regarding current trading prices, NXGLW is priced at $0.25, while MASI trades at $168.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas MASI's P/E ratio is -30.90. In terms of profitability, NXGLW's ROE is -0.63%, compared to MASI's ROE of -0.41%. Regarding short-term risk, NXGLW is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs RGEN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, RGEN has a market cap of 7.1B. Regarding current trading prices, NXGLW is priced at $0.25, while RGEN trades at $124.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas RGEN's P/E ratio is -301.05. In terms of profitability, NXGLW's ROE is -0.63%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, NXGLW is more volatile compared to RGEN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STVN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, STVN has a market cap of 6.8B. Regarding current trading prices, NXGLW is priced at $0.25, while STVN trades at $24.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas STVN's P/E ratio is 46.83. In terms of profitability, NXGLW's ROE is -0.63%, compared to STVN's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to STVN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MMSI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, MMSI has a market cap of 5.6B. Regarding current trading prices, NXGLW is priced at $0.25, while MMSI trades at $93.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas MMSI's P/E ratio is 46.07. In terms of profitability, NXGLW's ROE is -0.63%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to MMSI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs TFX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, TFX has a market cap of 5.4B. Regarding current trading prices, NXGLW is priced at $0.25, while TFX trades at $118.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas TFX's P/E ratio is 37.70. In terms of profitability, NXGLW's ROE is -0.63%, compared to TFX's ROE of +0.03%. Regarding short-term risk, NXGLW is more volatile compared to TFX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BLCO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, BLCO has a market cap of 4.8B. Regarding current trading prices, NXGLW is priced at $0.25, while BLCO trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas BLCO's P/E ratio is -13.19. In terms of profitability, NXGLW's ROE is -0.63%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to BLCO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HAE Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, HAE has a market cap of 3.7B. Regarding current trading prices, NXGLW is priced at $0.25, while HAE trades at $74.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas HAE's P/E ratio is 23.07. In terms of profitability, NXGLW's ROE is -0.63%, compared to HAE's ROE of +0.18%. Regarding short-term risk, NXGLW is more volatile compared to HAE. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ICUI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ICUI has a market cap of 3.3B. Regarding current trading prices, NXGLW is priced at $0.25, while ICUI trades at $132.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ICUI's P/E ratio is -35.23. In terms of profitability, NXGLW's ROE is -0.63%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, NXGLW is more volatile compared to ICUI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs XRAY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, XRAY has a market cap of 3.3B. Regarding current trading prices, NXGLW is priced at $0.25, while XRAY trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas XRAY's P/E ratio is -3.70. In terms of profitability, NXGLW's ROE is -0.63%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, NXGLW is more volatile compared to XRAY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs WRBY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, WRBY has a market cap of 2.6B. Regarding current trading prices, NXGLW is priced at $0.25, while WRBY trades at $21.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas WRBY's P/E ratio is -181.33. In terms of profitability, NXGLW's ROE is -0.63%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, NXGLW is more volatile compared to WRBY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs QDEL Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, QDEL has a market cap of 2B. Regarding current trading prices, NXGLW is priced at $0.25, while QDEL trades at $28.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas QDEL's P/E ratio is -5.70. In terms of profitability, NXGLW's ROE is -0.63%, compared to QDEL's ROE of -0.11%. Regarding short-term risk, NXGLW is more volatile compared to QDEL. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NVCR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, NXGLW is priced at $0.25, while NVCR trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas NVCR's P/E ratio is -11.84. In terms of profitability, NXGLW's ROE is -0.63%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, NXGLW is more volatile compared to NVCR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LMAT Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, NXGLW is priced at $0.25, while LMAT trades at $83.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas LMAT's P/E ratio is 42.48. In terms of profitability, NXGLW's ROE is -0.63%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to LMAT. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATRC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ATRC has a market cap of 1.6B. Regarding current trading prices, NXGLW is priced at $0.25, while ATRC trades at $32.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ATRC's P/E ratio is -39.75. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to ATRC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs AZTA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, NXGLW is priced at $0.25, while AZTA trades at $30.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas AZTA's P/E ratio is -9.71. In terms of profitability, NXGLW's ROE is -0.63%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, NXGLW is more volatile compared to AZTA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NNNN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, NNNN has a market cap of 1.4B. Regarding current trading prices, NXGLW is priced at $0.25, while NNNN trades at $31.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas NNNN's P/E ratio is 628.80. In terms of profitability, NXGLW's ROE is -0.63%, compared to NNNN's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to NNNN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BLFS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, BLFS has a market cap of 1B. Regarding current trading prices, NXGLW is priced at $0.25, while BLFS trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas BLFS's P/E ratio is -114.00. In terms of profitability, NXGLW's ROE is -0.63%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, NXGLW is more volatile compared to BLFS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs PLSE Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, PLSE has a market cap of 998.3M. Regarding current trading prices, NXGLW is priced at $0.25, while PLSE trades at $15.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas PLSE's P/E ratio is -14.99. In terms of profitability, NXGLW's ROE is -0.63%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, NXGLW is more volatile compared to PLSE. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STAA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, STAA has a market cap of 842.9M. Regarding current trading prices, NXGLW is priced at $0.25, while STAA trades at $16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas STAA's P/E ratio is -11.82. In terms of profitability, NXGLW's ROE is -0.63%, compared to STAA's ROE of -0.18%. Regarding short-term risk, NXGLW is more volatile compared to STAA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs KMTS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, KMTS has a market cap of 813.4M. Regarding current trading prices, NXGLW is priced at $0.25, while KMTS trades at $16.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas KMTS's P/E ratio is -8.25. In terms of profitability, NXGLW's ROE is -0.63%, compared to KMTS's ROE of +0.27%. Regarding short-term risk, NXGLW is more volatile compared to KMTS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATRI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, NXGLW is priced at $0.25, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ATRI's P/E ratio is 64.50. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATRI's ROE of +0.04%. Regarding short-term risk, NXGLW is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ANGO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ANGO has a market cap of 386.6M. Regarding current trading prices, NXGLW is priced at $0.25, while ANGO trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ANGO's P/E ratio is -9.33. In terms of profitability, NXGLW's ROE is -0.63%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, NXGLW is more volatile compared to ANGO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NYXH Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, NYXH has a market cap of 282.6M. Regarding current trading prices, NXGLW is priced at $0.25, while NYXH trades at $7.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas NYXH's P/E ratio is -3.24. In terms of profitability, NXGLW's ROE is -0.63%, compared to NYXH's ROE of -0.56%. Regarding short-term risk, NXGLW is more volatile compared to NYXH. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs SMTI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, SMTI has a market cap of 256.1M. Regarding current trading prices, NXGLW is priced at $0.25, while SMTI trades at $28.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas SMTI's P/E ratio is -21.50. In terms of profitability, NXGLW's ROE is -0.63%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, NXGLW is more volatile compared to SMTI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs OSUR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, OSUR has a market cap of 225.1M. Regarding current trading prices, NXGLW is priced at $0.25, while OSUR trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas OSUR's P/E ratio is -7.17. In terms of profitability, NXGLW's ROE is -0.63%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to OSUR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs UTMD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, UTMD has a market cap of 186.3M. Regarding current trading prices, NXGLW is priced at $0.25, while UTMD trades at $56.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas UTMD's P/E ratio is 15.13. In terms of profitability, NXGLW's ROE is -0.63%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, NXGLW is more volatile compared to UTMD. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STXS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, STXS has a market cap of 182.3M. Regarding current trading prices, NXGLW is priced at $0.25, while STXS trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas STXS's P/E ratio is -6.84. In terms of profitability, NXGLW's ROE is -0.63%, compared to STXS's ROE of -2.17%. Regarding short-term risk, NXGLW is more volatile compared to STXS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs KRMD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, KRMD has a market cap of 169.8M. Regarding current trading prices, NXGLW is priced at $0.25, while KRMD trades at $3.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas KRMD's P/E ratio is -30.67. In terms of profitability, NXGLW's ROE is -0.63%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, NXGLW is more volatile compared to KRMD. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs PDEX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, PDEX has a market cap of 142.1M. Regarding current trading prices, NXGLW is priced at $0.25, while PDEX trades at $43.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas PDEX's P/E ratio is 15.79. In terms of profitability, NXGLW's ROE is -0.63%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, NXGLW is more volatile compared to PDEX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs INFU Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, INFU has a market cap of 130.3M. Regarding current trading prices, NXGLW is priced at $0.25, while INFU trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas INFU's P/E ratio is 41.40. In terms of profitability, NXGLW's ROE is -0.63%, compared to INFU's ROE of +0.08%. Regarding short-term risk, NXGLW is more volatile compared to INFU. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ZTEK Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ZTEK has a market cap of 114.7M. Regarding current trading prices, NXGLW is priced at $0.25, while ZTEK trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ZTEK's P/E ratio is -15.71. In terms of profitability, NXGLW's ROE is -0.63%, compared to ZTEK's ROE of -0.58%. Regarding short-term risk, NXGLW is more volatile compared to ZTEK. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ZJYL Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ZJYL has a market cap of 100.2M. Regarding current trading prices, NXGLW is priced at $0.25, while ZJYL trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ZJYL's P/E ratio is 32.00. In terms of profitability, NXGLW's ROE is -0.63%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, NXGLW is more volatile compared to ZJYL. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MBOT Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, MBOT has a market cap of 90.6M. Regarding current trading prices, NXGLW is priced at $0.25, while MBOT trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas MBOT's P/E ratio is -3.89. In terms of profitability, NXGLW's ROE is -0.63%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, NXGLW is more volatile compared to MBOT. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs AKYA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, AKYA has a market cap of 65.9M. Regarding current trading prices, NXGLW is priced at $0.25, while AKYA trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas AKYA's P/E ratio is -1.38. In terms of profitability, NXGLW's ROE is -0.63%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, NXGLW is more volatile compared to AKYA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MLSS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, MLSS has a market cap of 51M. Regarding current trading prices, NXGLW is priced at $0.25, while MLSS trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas MLSS's P/E ratio is -10.83. In terms of profitability, NXGLW's ROE is -0.63%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, NXGLW is more volatile compared to MLSS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs OMIC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, NXGLW is priced at $0.25, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas OMIC's P/E ratio is -0.58. In terms of profitability, NXGLW's ROE is -0.63%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, NXGLW is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs IGAP Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, NXGLW is priced at $0.25, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas IGAP's P/E ratio is -10.52. In terms of profitability, NXGLW's ROE is -0.63%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, NXGLW is more volatile compared to IGAP. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs DXR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, DXR has a market cap of 47.9M. Regarding current trading prices, NXGLW is priced at $0.25, while DXR trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas DXR's P/E ratio is -107.22. In terms of profitability, NXGLW's ROE is -0.63%, compared to DXR's ROE of +0.02%. Regarding short-term risk, NXGLW is more volatile compared to DXR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NEPH Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, NEPH has a market cap of 42.7M. Regarding current trading prices, NXGLW is priced at $0.25, while NEPH trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas NEPH's P/E ratio is 50.38. In terms of profitability, NXGLW's ROE is -0.63%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to NEPH. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs POCI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, POCI has a market cap of 37.7M. Regarding current trading prices, NXGLW is priced at $0.25, while POCI trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas POCI's P/E ratio is -5.41. In terms of profitability, NXGLW's ROE is -0.63%, compared to POCI's ROE of -0.54%. Regarding short-term risk, NXGLW is more volatile compared to POCI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs SDC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, NXGLW is priced at $0.25, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas SDC's P/E ratio is -0.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to SDC's ROE of -1.96%. Regarding short-term risk, NXGLW is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs FEMY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, FEMY has a market cap of 27.3M. Regarding current trading prices, NXGLW is priced at $0.25, while FEMY trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas FEMY's P/E ratio is -1.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, NXGLW is more volatile compared to FEMY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs IVC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, NXGLW is priced at $0.25, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas IVC's P/E ratio is -0.79. In terms of profitability, NXGLW's ROE is -0.63%, compared to IVC's ROE of -0.46%. Regarding short-term risk, NXGLW is more volatile compared to IVC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NXGL Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, NXGL has a market cap of 20.7M. Regarding current trading prices, NXGLW is priced at $0.25, while NXGL trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas NXGL's P/E ratio is -6.00. In terms of profitability, NXGLW's ROE is -0.63%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, NXGLW is more volatile compared to NXGL. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HBIO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, HBIO has a market cap of 19.8M. Regarding current trading prices, NXGLW is priced at $0.25, while HBIO trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas HBIO's P/E ratio is -0.34. In terms of profitability, NXGLW's ROE is -0.63%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, NXGLW is more volatile compared to HBIO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs RVP Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, RVP has a market cap of 19.5M. Regarding current trading prices, NXGLW is priced at $0.25, while RVP trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas RVP's P/E ratio is -0.86. In terms of profitability, NXGLW's ROE is -0.63%, compared to RVP's ROE of -0.27%. Regarding short-term risk, NXGLW is more volatile compared to RVP. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs WOK Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, WOK has a market cap of 17.7M. Regarding current trading prices, NXGLW is priced at $0.25, while WOK trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas WOK's P/E ratio is -2.63. In terms of profitability, NXGLW's ROE is -0.63%, compared to WOK's ROE of -0.30%. Regarding short-term risk, NXGLW is more volatile compared to WOK. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LUCYW Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, LUCYW has a market cap of 13.8M. Regarding current trading prices, NXGLW is priced at $0.25, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas LUCYW's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, NXGLW is more volatile compared to LUCYW. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MHUA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, MHUA has a market cap of 13.1M. Regarding current trading prices, NXGLW is priced at $0.25, while MHUA trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas MHUA's P/E ratio is 1.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to MHUA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs EKSO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, EKSO has a market cap of 8.1M. Regarding current trading prices, NXGLW is priced at $0.25, while EKSO trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas EKSO's P/E ratio is -0.47. In terms of profitability, NXGLW's ROE is -0.63%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, NXGLW is more volatile compared to EKSO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs POAI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, POAI has a market cap of 7.4M. Regarding current trading prices, NXGLW is priced at $0.25, while POAI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas POAI's P/E ratio is -0.58. In terms of profitability, NXGLW's ROE is -0.63%, compared to POAI's ROE of -5.91%. Regarding short-term risk, NXGLW is more volatile compared to POAI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LUCY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, LUCY has a market cap of 6.5M. Regarding current trading prices, NXGLW is priced at $0.25, while LUCY trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas LUCY's P/E ratio is 0.05. In terms of profitability, NXGLW's ROE is -0.63%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, NXGLW is more volatile compared to LUCY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STSS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, STSS has a market cap of 5.6M. Regarding current trading prices, NXGLW is priced at $0.25, while STSS trades at $5.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas STSS's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to STSS's ROE of -0.99%. Regarding short-term risk, NXGLW is more volatile compared to STSS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NSTG Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, NXGLW is priced at $0.25, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas NSTG's P/E ratio is -0.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, NXGLW is more volatile compared to NSTG. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs GCTK Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, GCTK has a market cap of 3.6M. Regarding current trading prices, NXGLW is priced at $0.25, while GCTK trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas GCTK's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, NXGLW is more volatile compared to GCTK. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs GMVD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, NXGLW is priced at $0.25, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas GMVD's P/E ratio is -0.01. In terms of profitability, NXGLW's ROE is -0.63%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, NXGLW is more volatile compared to GMVD. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs GMVDW Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, NXGLW is priced at $0.25, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas GMVDW's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, NXGLW is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs AVGR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, NXGLW is priced at $0.25, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas AVGR's P/E ratio is -0.05. In terms of profitability, NXGLW's ROE is -0.63%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, NXGLW is more volatile compared to AVGR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs IIN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, IIN has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas IIN's P/E ratio is 226.45. In terms of profitability, NXGLW's ROE is -0.63%, compared to IIN's ROE of -0.00%. Regarding short-term risk, NXGLW is more volatile compared to IIN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HRC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, HRC has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas HRC's P/E ratio is 41.92. In terms of profitability, NXGLW's ROE is -0.63%, compared to HRC's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to HRC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LMNX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, LMNX has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while LMNX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas LMNX's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to LMNX's ROE of +0.03%. Regarding short-term risk, NXGLW is more volatile compared to LMNX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs APR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, APR has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas APR's P/E ratio is 22.59. In terms of profitability, NXGLW's ROE is -0.63%, compared to APR's ROE of +9.81%. Regarding short-term risk, NXGLW is more volatile compared to APR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATRS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 20M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.22, whereas ATRS's P/E ratio is 14.95. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, NXGLW is more volatile compared to ATRS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.